Merck KGaA continues expansion with $285M+ investment in 2 new projects in France and Germany

The company is looking to invest around €130 million ($129 million) into single-use assemblies as part of the production of Covid-19 vaccines and other therapeutics at its site in Molsheim, France, a city in the east of the country. The investment in the 50-year-old site will also aim to create around 800 jobs by 2028.